Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Classifying microembolic signals seen on transcranial Doppler ultrasound in stroke research

Experts review blood-flow ultrasound recordings to classify tiny clots in adults at risk of stroke.

Plain-language title generated from the registry record
Registry title: A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]

Key facts

Where
Porto, PortugalSee the site

Where in Portugal

  • Faculty of Medicine University PortoPorto, PortugalNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Universidade do Porto
Trial code
NCT07172165
Record updated
10 December 2025
Original description
Microembolic signals (MES) is a powerful predictor of future embolic events. This study aims to develop and validate a accurate model of classification of MES obtained by transcranial Doppler. monitoring of However, MES detection is technically demanding and requires expert interpretation. By providing a reproducible framework for MES interpretation, this work aims to facilitate MES integration into future clinical trials and decision-making.Read full original descriptionShow less

A Multicenter Study to Optimize Microembolic Signal Classification Based on Double--Blind Multiparametric Assessment by Human Experts Using an Universal Graphical Interface [MESOMEGA]

Microembolic signals (MES) is a powerful predictor of future embolic events. This study aims to develop and validate a accurate model of classification of MES obtained by transcranial Doppler. monitoring of However, MES detection is technically demanding and requires expert interpretation. By providing a reproducible framework for MES interpretation, this work aims to facilitate MES integration into future clinical trials and decision-making.

Inclusion: MES of presumed solid form or non-MES high intensity transient signals; Obtained from on a human subject with age equal to or more than 18years old; Obtained from proximal middle cerebral artery (M1 segment); Clip with 20 seconds duration with clearly event of interest marked using TCDPlayer; With an overall background spectrum of reasonable quality to be analyzed.

Exclusion: Use of ultrasound contrast agent or agitated saline in the previous 24 hours; Obtained from patient during any cardiac surgery or endovascular procedure1; MES in gaseous form; Obtained from patients with mechanical valve; Obtained from patient with recent severe trauma; Clips with multiples inseparable MES (e.g. curtain).

ClinicalTrials.gov NCT07172165